Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
890.2 INR | -0.64% | +0.82% | -2.17% |
Sales 2024 * | 19.71B 236M 324M | Sales 2025 * | 26.49B 318M 435M | Capitalization | 121B 1.45B 1.99B |
---|---|---|---|---|---|
Net income 2024 * | 4.1B 49.1M 67.27M | Net income 2025 * | 4.38B 52.48M 71.9M | EV / Sales 2024 * | 6.68 x |
Net Debt 2024 * | 10.44B 125M 171M | Net Debt 2025 * | 11.22B 134M 184M | EV / Sales 2025 * | 5 x |
P/E ratio 2024 * |
29.8
x | P/E ratio 2025 * |
27.5
x | Employees | 3,548 |
Yield 2024 * |
0.76% | Yield 2025 * |
0.76% | Free-Float | 24.65% |
Latest transcript on Eris Lifesciences Limited
1 day | -0.64% | ||
1 week | +0.82% | ||
Current month | +5.56% | ||
1 month | +4.73% | ||
3 months | -2.95% | ||
6 months | +3.57% | ||
Current year | -2.17% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 50 | 07-01-26 | |
Vijay S. Joshi
PSD | President | - | 10-04-30 |
Sachin Shah
DFI | Director of Finance/CFO | 44 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kalpana Unadkat
BRD | Director/Board Member | 53 | 21-01-04 |
Prashant Gupta
BRD | Director/Board Member | 44 | 18-04-29 |
Chief Executive Officer | 50 | 07-01-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 117 M€ | +0.43% | - | |
0.00% | 7 M€ | +2.58% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 890.2 | -0.64% | 359 161 |
24-04-30 | 896 | +0.27% | 535,447 |
24-04-29 | 893.5 | +0.06% | 44,956 |
24-04-26 | 893 | +1.06% | 58,767 |
24-04-25 | 883.6 | +1.55% | 62,936 |
Delayed Quote NSE India S.E., May 02, 2024 at 07:43 am
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.17% | 1.46B | |
+30.08% | 699B | |
+25.07% | 571B | |
-4.71% | 364B | |
+17.97% | 326B | |
+2.74% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.39% | 154B |
- Stock Market
- Equities
- ERIS Stock